Trial shows Huntington's drug could slow progress of disease
Guardian - 11-Dec-2017Drug suppresses the effects of the Huntington’s mutation that causes irreversible damage to the b...
Join the club for FREE to access the whole archive and other member benefits.
Professor of Clinical Neurology at UCL Institute of Neurology.
Prof Sarah Tabrizi is an award winning scientist who has published over 300 peer-reviewed publications, been elected a fellow of the UK Academy of Medical Sciences, co-founded the UCL Huntington’s Disease Centre and helped set up the UK All-Party Parliamentary Group for Huntington's disease. Her complementary research strategies - basic science focusing on cellular mechanisms of neurodegeneration, and a programme to translate those findings into treatments and cures - have led to exciting Phase I results from a novel ‘gene silencing’ treatment in Huntington's disease. Sarah was presented with the Yahr Award and Alexander Morison Medal in 2019 for her contributions to research.
Visit website: https://www.ucl.ac.uk/school-life-medical-sciences/sarah-tabrizi
See also: University College London (UCL) - Diverse global community of world-class academics, students, industry links, external partners, and alumni
Details last updated 23-Apr-2020
Drug suppresses the effects of the Huntington’s mutation that causes irreversible damage to the b...